CASE STUDY: Meet a F100 pharmaceutical company that doesn’t sweat highly regulated, high-volume, urgent language translations

For pharmaceutical companies regulation matters, even on social media

It may have taken the FDA a while to start regulating copy related to pharmaceutical products on social media, but rest assured: the day has come.

Read more